Paul Shafer highlights newly federal rule aimed at streamlining application and renewal processes for enrolling in Medicaid and CHIP.
Medicare
Posted inCost of Care
The Race to Prepare for Medicare’s New Drug Pricing Powers
Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Posted inHealth Equity
Breaking Down Biden’s New Nondiscrimination Rule
Katie Keith shares about a newly proposed rule to Section 1557, a civil rights pillar of the Affordable Care Act.
Posted inCost of Care
Dems’ New Drug Pricing Deal: What You Need to Know
Stacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Posted inCost of Care
Do Higher Hospital Prices Reflect Greater Investments in Quality?
Benedic Ippolito shares new research that examines whether hospitals with higher prices also offer higher quality care.
Posted inCost of Care
Hospitals Scooping Up Physician Practices Drives Health Care Prices Up
Aditi Sen shares new research that examines whether hospital consolidation increases health care prices.
Posted inHealth Equity
Looking for Causes of Racial Disparities in Medicare Advantage
Adrianna McIntyre shares new research showing non-white communities have less access to high quality Medicare Advantage plans.
Posted inCost of Care
High-Price Drugs Out of Reach for Many on Medicare
Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
Posted inCost of Care
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
Posted inCost of Care
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.